Podcast: Play in new window | Download
Leukemia
- Leukemia is a disease characterized by the overproduction of a particular type of blood cell.
- This process often inhibits the production of normal blood cells
- These leukemia cells do not function as proper cells
- Leukemia does not form a solid tumor. Rather it produces blood cells which may infiltrate tissue.
- Leukemic cells have unusually long lives and avoid preprogramed cell death or apoptosis
- Swollen lymph glands and an enlarged spleen are often seen due to collecting WBC’s
- Acute leukemia is when the overproduction occurs rapidly and there is a fast increase in the number of WBCs. These cells tend to be immature blasts.
- Chronic Leukemia is the slower build up of mature but abnormal and non-functioning WBCs.
- The type of leukemia depends on the specific type of cell being produced.
- Multipotential hematopoietic stem cells produce either myeloid progenitor cells or lymphoid progenitor cells
- Lymphoid progenitor cells produce
- B lymphocytes
- Plasma cells
- T lymphocytes
- Natural killer cells
- Myeloid progenitor cells produce
- Megakaryocytes
- Thrombocytes
- Erythrocytes
- Mast cells
- Myeloblasts
- Basophils
- Neutrophils
- Eosinophils
- Macrophages
- Lymphoid progenitor cells produce
- Lymphocytic leukemia is characterized by the overproduction of lymphocytes
- Myelogenous leukemia is characterized by the overproduction of red blood cells as well as some white blood cells and platelets
- You can then pair the two cell types of with the two time frames
- Acute lymphocytic leukemia (ALL)
- Chronic lymphocytic leukemia (CLL)
- Acute myelogenous leukemia (AML)
- Chronic myelogenous leukemia (CML)
Acute lymphocytic leukemia (ALL)
- Excessive lymphoblasts
- Abnormal cells produced have unusually long lives
- These leukemia cells have the ability to infiltrate organs and the Central Nervous System
- Most commonly found between the ages of 2 & 5 but can effect any age group
- This is the most common form of leukemia in children
- Overcrowding of the bone marrow is the main issue
Clinical Presentation
-
Anemia
- Weakness
- Fatigue
- Tachycardia
-
Thrombocytopenia
- Petechia
- Epistaxis
- Bleeding gums
-
Organ infiltration
- Bone and joint pain
- Enlarged lymph nodes and liver
- Headaches
- Visual and audio disturbances
- Infections / Fever
Labs & Studies & Physical Exam Findings
- Enlarged lymph nodes
-
CBC
- Elevated white blood cell count
- Pancytopenia
-
Peripheral blood smear
- Elevated blasts
- Pancytopenia with circulating blasts
- Bone marrow biopsy with elevated blast cells
- Cytogenetics – Looking for B and T lymphocytes
- Cytogenetics, cytochemical stains and flow cytometry are used to determine subtypes and distinguish AML from ALL
- CT or ultrasound may be used to determine organ infiltration
Treatment
-
Supportive care
- Deal promptly with infections
- Maintain good hydration
- Transfusions
- Chemotherapy
- Steroids and methotrexate
- Bone marrow transplant
- Survival rates range from 20-75% depending on the characteristics and subtype of disease
Chronic Lymphocytic Leukemia (CLL)
- Chronic lymphocytic leukemia is also known as B cell leukemia because it is usually monoclonal malignant B cells
- The most common type of leukemia
- Most commonly diagnosed in men over 50 years old
Clinical Presentation
- Routine physical exam – most patients are asymptomatic early in the disease process
-
Vague symptoms
- Fatigue
- Weakness
- Weight loss
- Night sweats
Labs, Studies and Physical Exam Findings
- Lymphadenopathy
- Splenomegaly
- Hepatomegaly
- CBC with with WBCs greater than 20,000 and lymphocytes greater than 5,000
- Flow cytometry can be used to test for monoclonal B cells
- Bone marrow biopsy showing small lymphocytes
- Lymph Node biopsy
Treatment
-
Supportive care
- Deal promptly with infections
- Maintain good hydration
- Transfusions
- Chemotherapy
- Radiation
- Bone marrow transplant
- Splenectomy
- Prognosis is between 2 and 20 years depending on subtype
Acute Myelogenous Leukemia (AML)
- AML is more often seen in adults
Clinical Presentation
-
Anemia
- Weakness
- Fatigue
- Tachycardia
-
Thrombocytopenia
- Petechia
- Epistaxis
- Bleeding gums
-
Organ infiltration (less frequent than ALL)
- Bone and joint pain
- Enlarged lymph nodes and liver
- Headaches
- Visual and audio disturbances
Labs, studies and Physical Exam Findings
- Enlarged lymph nodes are rare
-
CBC
- Elevated white blood cell count
- Pancytopenia
-
Peripheral blood smear
- Elevated blasts (may make up to 90% of WBCs)
- Pancytopenia
- Bone marrow biopsy with elevated blast cells
-
Peripheral blood smear
- Auer rods are pathognomonic for AML
- Cytogenetics, cytochemical stains and flow cytometry are used to determine subtypes and distinguish AML from ALL
Treatment
-
Supportive care
- Deal promptly with infections
- Maintain good hydration
- Transfusions
- Chemotherapy
- Stem cell transplant
Chronic myelogenous leukemia (CML)
- Mean age of diagnosis is 65 years old
- An abnormal pluripotent hematopoietic progenitor cell starts reproducing
-
Unregulated growth of many different types of cells are possible
- Red Blood Cells
- Neutrophils
- Eosinophils
- Basophils
- Megakaryocytes
- etc
-
Three phases
-
Chronic
- Stable period last about five years
-
Accelerated
- Symptoms become difficult to treat
-
Blast
- Similar to acute leukemia with an overwhelming number of blasts
-
Chronic
- The Philadelphia Chromosome is present in almost all cases
- CML will end in blast phase which is much like an acute leukemia
Clinical Presentation
- Most patients are asymptomatic and in the Chronic phase
-
As a patient enters the accelerated phase vague symptoms begin to appear
- Fatigue
- Weakness
- Abdominal fullness
- Weight loss
- Night sweats
-
Splenomegaly
- Enlarged spleen may cause left upper quadrant pain or loss of appetite
- Enlarged lymph nodes
- Bleeding and bruising
- Pallor
- Shortness of breath
Labs, studies and physical exam findings
-
CBC with WBC’s as high as 150,000 with elevated granulocytes
- neutrophils
- eosinophils
- basophils
- Peripheral blood smear
- Bone marrow biopsy – Philadelphia Chromosome is pathognomonic for CML
Treatment
- Bone marrow transplant or stem cell transplant may be curative
- Tyrosine kinase inhibitors
- Myelosuppressive therapy
- Splenectomy
- Median survival had been between 3 & 5 years. With tyrosine kinase inhibitors and other medical treatment 7-10 years is more normal today.
Key terms and ideas
-
Acute lymphocytic leukemia (ALL)
- Found in kids 2-5
- Lots of circulating blasts
-
Chronic lymphocytic leukemia (CLL)
- Patients are usually men over 50
- Patients typically have no symptoms
-
Acute myelogenous leukemia (AML)
- Found in adults
- Pancytopenia with circulating blasts
- Auer rods are pathognomonic for AML
-
Chronic myelogenous leukemia (CML)
- Found in adults
- Most patients are asymptomatic at diagnosis
- Radiation exposure is a risk factor
- Philadelphia Chromosome is pathognomonic for CML